Alginate fiber with photo-thermal controllable antibacterial function and preparation method thereof

By introducing polydopamine and zinc oxide into sodium alginate, seaweed fibers with photothermal controllable antibacterial functions are solved, and the problems of antibacterial particle release rate control and excessive use of antibiotics in the prior art are solved, and the biological phase of seaweed fibers is realized Capacitive and continuous antibacterial effect, suitable for medical dressings and wound repair.

CN119061529AActive Publication Date: 2024-12-03XI'AN POLYTECHNIC UNIVERSITY

Patent Information

Application Number
CN202411177071.9
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-26
Publication Date
2024-12-03
Estimated Expiration
2044-08-26

AI Technical Summary

Technical Problem

Existing medical antibacterial fiber materials have shortcomings in controlling the release rate of antibacterial particles and avoiding excessive use of antibiotics, and it is difficult to achieve sustainable and effective antibacterial function and biocompatibility.

Method used

By introducing polydopamine and zinc oxide into sodium alginate, the release of antibacterial components is achieved through photothermal controllable method. Dopamine hydrochloride and trimethylolamide aminomethane are used to react in sodium alginate solution to form polydopamine, combined with zinc The salt and alkaline solution are cross-linked to form seaweed fibers with photothermal controllable antibacterial functions.

Benefits of technology

It realizes the biocompatibility, degradability and excellent antibacterial properties of seaweed fibers, and has good photothermal controllable antibacterial functions, which are suitable for tissue growth and wound repair, and has significant application performance advantages.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119061529A_ABST
    Figure CN119061529A_ABST
Patent Text Reader

Abstract

The invention discloses alginate fiber with a photo-thermal controllable antibacterial function and a preparation method of the alginate fiber. Dopamine hydrochloride and trihydroxymethyl aminomethane are added into a sodium alginate solution, and a sodium alginate / polydopamine solution is obtained; adding a zinc salt solution and an alkaline solution into the sodium alginate solution to obtain a sodium alginate / zinc oxide solution; the preparation method comprises the following steps: mixing a sodium alginate / polydopamine solution with a sodium alginate / zinc oxide solution to form a spinning solution, taking a zinc salt aqueous solution as a coagulating bath, and forming the polydopamine / zinc oxide composite modified antibacterial alginate fiber through a wet spinning process. The antibacterial alginate fiber prepared by the invention has good air permeability and moisture absorption characteristics, and meanwhile, the controllable release of antibacterial components is realized. The textile medical dressing prepared from the antibacterial fiber has remarkable performance advantages in the aspects of absorbing wound exudate, avoiding infection, promoting wound healing and the like.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the field of medical composite materials, and particularly relates to a seaweed fiber with photothermal controllable antibacterial function and a preparation method thereof. Background Art

[0002] The development background of medical antibacterial functional fibers mainly stems from the medical field's demand for preventing infection and improving sanitary conditions. With the advancement of medical technology and the improvement of patients' requirements for medical care, the deficiencies in the antibacterial properties of traditional fiber materials have gradually become apparent. The development of intelligent, controllable, non-toxic, continuously antibacterial, and biocompatible antibacterial fiber materials has always been a problem that needs to be urgently solved in the fields of scientific research and medical applications. Sodium alginate is a natural linear polymer polysaccharide that has great potential in the medical field due to its good biocompatibility and degradability, but sodium alginate itself does not have antibacterial function, which limits its application in the medical field.

[0003] Doping with antibacterial ingredients is an effective way to give sodium alginate antibacterial properties. Researchers added silver nanoparticles to sodium alginate hydrogels, giving the material good antibacterial properties, but silver particles have potential biotoxicity and can easily cause cell hemolysis. Some researchers also used tannic acid as an antibacterial agent and blended it with sodium alginate and glycerol to develop an antibacterial cotton gauze that has good antibacterial activity against a variety of bacteria, but the composite material cannot control the release rate of antibacterial particles according to the wound condition. Medical dressings with good biocompatibility, sustained antibacterial and controlled sustained-release functions have always been urgently needed products in clinical applications.

[0004] Polydopamine is an artificial melanin inspired by mussels, which is formed by the slow oxidation polymerization of dopamine hydrochloride in an alkaline solution. Polydopamine contains a large number of functional groups such as catechol and imine, which can not only form hydrogen bonds or covalent bonds with polymers containing functional groups such as phenol, amine, and thiol, but also form chelation with metal ions. Therefore, the introduction of polydopamine can often improve the mechanical properties of composite materials. At the same time, due to its excellent photothermal properties, antioxidant capacity, and good biocompatibility, polydopamine has broad application prospects in the medical field.

[0005] Some researchers have prepared hydrogels by physically cross-linking antibiotic-loaded polydopamine and nanocellulose, which can control the release rate of drugs under near-infrared light or low pH conditions. However, the widespread use of antibiotics can cause bacteria to develop drug resistance. Zinc oxide has good biosafety, chemical stability, and significant antibacterial activity, and is widely recognized in terms of antibacterial, anti-inflammatory, and wound healing. Zinc oxide as an antibacterial material is helpful in avoiding the excessive use of antibiotics. Zinc is an essential element for maintaining the activity of human mechanisms. When zinc oxide comes into contact with the wound, it can ionize zinc ions, providing essential elements for wound healing while avoiding wound infection. It is well known that in the dynamic process of wound healing, achieving controlled release of antibacterial components and ensuring the continued effectiveness of the antibacterial function of the material are important features of the application of ideal medical materials, which is precisely what traditional materials are difficult to achieve. Summary of the invention

[0006] In order to solve the above-mentioned defects existing in the prior art, the purpose of the present invention is to provide a seaweed fiber with photothermally controllable antibacterial function and a preparation method thereof. The seaweed fiber with photothermally controllable antibacterial function prepared by this method not only maintains the biocompatibility and degradability of sodium alginate, but also, due to the introduction of polydopamine and zinc oxide, gives the material good photothermally controllable antibacterial function while ensuring the excellent antibacterial properties of the composite material.

[0007] The present invention is achieved through the following technical solutions.

[0008] One aspect of the present invention provides a method for preparing seaweed fiber with photothermal controllable antibacterial function, comprising the following steps:

[0009] (a) adding dopamine hydrochloride and tris(hydroxymethylaminomethane) to a sodium alginate solution in a ratio of 10-50% of the mass of dopamine hydrochloride to the mass of sodium alginate and 1-10% of the mass of tris(hydroxymethylaminomethane) to the mass of sodium alginate, stirring and reacting to obtain a sodium alginate / polydopamine solution;

[0010] (b) adding a zinc salt solution and an alkaline solution to the sodium alginate solution in a mass ratio of (100-120):(8-14):(12-16), heating and stirring to react, and obtaining a sodium alginate / zinc oxide solution;

[0011] (c) mixing a sodium alginate / polydopamine solution with a sodium alginate / zinc oxide solution in a mass ratio of (100-120):(120-150), injecting the mixed solution into a metal salt aqueous solution coagulation bath through a spinneret using a syringe pump, and chelating and cross-linking the sodium alginate into fibers; washing the obtained fibers with deionized water and drying them to obtain seaweed fibers.

[0012] Preferably, the mass concentration of the sodium alginate solution is 0.5-5%.

[0013] Preferably, the stirring temperature of dopamine hydrochloride in the sodium alginate solution is 10-30° C. and the stirring time is 4-8 hours.

[0014] Preferably, the zinc salt is one or more of zinc sulfate, zinc nitrate, zinc chloride and zinc acetate.

[0015] Preferably, the alkaline solution is one or more of a sodium hydroxide solution, a potassium hydroxide solution and a calcium hydroxide solution.

[0016] Preferably, the concentration of the zinc salt solution is 0.1-0.25 mol / L; the concentration of the alkaline solution is 0.1-1 mol / L; the stirring temperature is 40-60° C., and the stirring time is 2-4 hours.

[0017] Preferably, the metal salt in the metal salt aqueous solution coagulation bath is one or more of calcium chloride, strontium chloride, zinc chloride and copper chloride.

[0018] Preferably, the mass concentration of the metal salt aqueous solution in the coagulation bath is 1-5%; the temperature of the sodium alginate chelating cross-linking fiber forming is 10-30°C.

[0019] Another aspect of the present invention provides a seaweed fiber with photothermal controllable antibacterial function prepared by the method.

[0020] The present invention adopts the above technical solution, which has the following beneficial effects:

[0021] 1. The composite antibacterial functional fiber prepared by the present invention is composed of zinc oxide synthesized in situ based on sodium alginate, polydopamine synthesized in situ and sodium alginate chelated and cross-linked by metal salts. The composite antibacterial functional fiber not only maintains the biocompatibility and degradability of sodium alginate, but also, due to the introduction of polydopamine and zinc oxide, gives the material good photothermal controllable antibacterial function while ensuring the excellent antibacterial properties of the composite material.

[0022] 2. The preparation of sodium alginate solution, in-situ synthesis of zinc oxide and synthesis of polydopamine in the present invention are simple and easy, the spinning preparation process is green and environmentally friendly, and the cost is low. The prepared fiber has good moisture absorption and air permeability and controllable antibacterial properties. The seaweed fiber with photothermal controllable antibacterial function and the preparation method thereof have broad application prospects in the treatment of tissue growth and postoperative wound repair.

[0023] 3. The seaweed fiber prepared by the present invention has good air permeability and moisture absorption properties, and at the same time, the photothermal effect of polydopamine is used to achieve the controlled release of antibacterial components. The textile medical dressing prepared by the fiber has significant application performance advantages in clinical treatments such as chronic wound care and postoperative wound repair.

[0024] Other features and advantages of the present invention will be described in the following detailed description. BRIEF DESCRIPTION OF THE DRAWINGS

[0025] The drawings described herein are used to provide a further understanding of the present invention, constitute a part of the present application, and do not constitute an improper limitation of the present invention. In the drawings:

[0026] Figure 1 The present invention shows a process flow chart of a seaweed fiber with photothermal controllable antibacterial function and a preparation method thereof and its application;

[0027] Figures 2(a) and (b) respectively show the photothermal effect of the seaweed fiber with photothermal controllable antibacterial function in the present invention; Figure 2(a) is the surface temperature-time curve of the composite film under 100W and 250W near-infrared light; Figure 2(b) is the optical and infrared images of the composite film surface under 250W near-infrared light at different times;

[0028] Figure 3 The antibacterial effect of the seaweed fiber with photothermal controllable antibacterial function in the present invention is shown. DETAILED DESCRIPTION

[0029] The present invention will be described in detail below in conjunction with the accompanying drawings and specific embodiments. The exemplary embodiments and descriptions of the present invention are used to explain the present invention but are not intended to limit the present invention.

[0030] The present invention provides a method for preparing seaweed fiber with photothermal controllable antibacterial function, comprising the following steps:

[0031] Step 1, prepare sodium alginate solution:

[0032] Sodium alginate is placed in deionized water to obtain a sodium alginate solution with a concentration of 0.5-5%.

[0033] Step 2, preparing polydopamine / sodium alginate solution:

[0034] According to the mass of dopamine hydrochloride accounting for 10-50% of the mass of sodium alginate, the mass of tris(hydroxymethyl)aminomethane accounting for 1-10% of the mass of sodium alginate, dopamine hydrochloride and tris(hydroxymethyl)aminomethane are added to a sodium alginate solution with a mass concentration of 0.5-5%, and the mixture is stirred for reaction at a temperature of 10-30°C for 4-8 hours. When the color of the solution changes to black, it is proved that polydopamine is synthesized in the sodium alginate solution, so as to obtain a sodium alginate / polydopamine solution.

[0035] In step 2, the addition of tris(hydroxymethyl)aminomethane) provides an alkaline environment for the oxidative polymerization of dopamine hydrochloride; dopamine hydrochloride is polymerized in situ in the sodium alginate solution to form polydopamine, and the hydrogen bonding effect formed between sodium alginate and polydopamine ensures the uniform dispersion of polydopamine in the solution system.

[0036] Step 3, in situ synthesis of zinc oxide:

[0037] Using sodium alginate as a template, 0.1-0.25 mol / L zinc salt solution and 0.1-1 mol / L alkaline solution are added to the sodium alginate solution in a mass ratio of (100-120):(8-14):(12-16), the stirring temperature is 40-60°C, the stirring time is 2-4 hours, and when the color of the solution turns milky white, it proves that zinc oxide is successfully synthesized to obtain a sodium alginate / zinc oxide solution.

[0038] The zinc salt solution is one or more of zinc sulfate solution, zinc nitrate solution, zinc chloride solution and zinc acetate solution; the alkaline solution is one or more of sodium hydroxide solution, potassium hydroxide solution and calcium hydroxide solution.

[0039] In step 3, the addition of zinc salt solution forms metal ion chelating cross-linking points in the sodium alginate solution system, while the addition of alkaline solution in situ synthesizes zinc oxide at the network cross-linking points of the formed zinc ion micro-cross-linked sodium alginate; zinc oxide can effectively ionize zinc ions in water, occupy the hydrophilic space in the sodium alginate molecular chain network through ion replacement, and thus effectively improve the antibacterial properties of sodium alginate.

[0040] Step 4, preparing seaweed fiber:

[0041] Sodium alginate / polydopamine solution and sodium alginate / zinc oxide solution are mixed in a mass ratio of (100-120): (120-150), and the mixed solution is injected into a coagulation bath of a metal salt (one or more of calcium chloride, strontium chloride, zinc chloride and copper chloride) aqueous solution with a mass concentration of 1-5% through a spinneret hole using an injection pump to carry out chelation cross-linking of the sodium alginate into fibers at a cross-linking temperature of 10-30°C. The obtained fibers are washed with deionized water and dried to obtain seaweed fibers with photothermal controllable antibacterial functions.

[0042] In step 4, the metal ions replace the sodium ions in the sodium alginate through substitution, forming an "egg box" structure with the metal ions as the core; the zinc oxide is completely encapsulated inside the seaweed fiber, providing a stable antibacterial component for the antibacterial properties of the seaweed fiber.

[0043] The present invention is further described in detail below through specific embodiments.

[0044] Example 1

[0045] Step 1, prepare sodium alginate solution:

[0046] 0.5 g of sodium alginate was placed in 100 ml of deionized water to obtain a sodium alginate solution with a concentration of 0.5%.

[0047] Step 2, preparing polydopamine / sodium alginate solution:

[0048] According to the mass of dopamine hydrochloride being 10% of the mass of sodium alginate, the mass of tris(hydroxymethyl)aminomethane being 5% of the mass of sodium alginate, dopamine hydrochloride and tris(hydroxymethyl)aminomethane are added to a sodium alginate solution with a mass concentration of 0.5%, the stirring temperature is 10°C, the stirring time is 8 hours, and when the color of the solution turns black, it is proved that polydopamine is synthesized in the sodium alginate solution to obtain a sodium alginate / polydopamine solution.

[0049] Step 3, in situ synthesis of zinc oxide:

[0050] Using sodium alginate as a template, add 0.15 mol / L zinc sulfate solution and 0.5 mol / L sodium hydroxide solution to the sodium alginate solution in a mass ratio of 100:14:15, stir at 50°C for 3 hours, and when the color of the solution turns milky white, it proves that zinc oxide is successfully synthesized to obtain a sodium alginate / zinc oxide solution.

[0051] Step 4, preparing seaweed fiber:

[0052] Sodium alginate / polydopamine solution and sodium alginate / zinc oxide solution were mixed in a mass ratio of 100:140, and the mixed solution was injected into a coagulation bath with a mass concentration of 3% zinc chloride through a spinneret using a syringe pump to carry out chelation cross-linking of the sodium alginate into fibers at a cross-linking temperature of 20°C. The fibers were washed with deionized water to obtain a seaweed fiber with photothermal controllable antibacterial function.

[0053] Example 2

[0054] Step 1, prepare sodium alginate solution:

[0055] 5 g of sodium alginate was placed in 100 ml of deionized water to obtain a sodium alginate solution with a concentration of 5%.

[0056] Step 2, preparing polydopamine / sodium alginate solution:

[0057] According to the mass of dopamine hydrochloride being 30% of the mass of sodium alginate, the mass of tris(hydroxymethyl)aminomethane being 10% of the mass of sodium alginate, dopamine hydrochloride and tris(hydroxymethyl)aminomethane are added to a sodium alginate solution with a mass concentration of 5%, the stirring temperature is 30°C, the stirring time is 4 hours, and when the color of the solution turns black, it is proved that polydopamine is synthesized in the sodium alginate solution to obtain a sodium alginate / polydopamine solution.

[0058] Step 3, in situ synthesis of zinc oxide:

[0059] Using sodium alginate as a template, add 0.25 mol / L zinc chloride solution and 1 mol / L potassium hydroxide solution + 1 mol / L calcium hydroxide solution into the sodium alginate solution in a mass ratio of 120:10:16. Stir at 40°C for 4 hours. When the color of the solution turns milky white, it proves that zinc oxide is successfully synthesized to obtain a sodium alginate / zinc oxide solution.

[0060] Step 4, preparing seaweed fiber:

[0061] Sodium alginate / polydopamine solution and sodium alginate / zinc oxide solution were mixed in a mass ratio of 120:150, and the mixed solution was injected into a coagulation bath with a mass concentration of 5% calcium chloride and a mass concentration of 5% copper chloride through a spinneret using a syringe pump to carry out chelating cross-linking of sodium alginate into fibers. The cross-linking temperature was 10°C, and the obtained fibers were washed with deionized water and dried to obtain seaweed fibers with photothermal controllable antibacterial functions.

[0062] Example 3

[0063] Step 1, prepare sodium alginate solution:

[0064] 1 g of sodium alginate was placed in deionized water to obtain a sodium alginate solution with a concentration of 1%.

[0065] Step 2, preparing polydopamine / sodium alginate solution:

[0066] According to the mass of dopamine hydrochloride being 50% of the mass of sodium alginate, the mass of tris(hydroxymethyl)aminomethane being 1% of the mass of sodium alginate, dopamine hydrochloride and tris(hydroxymethyl)aminomethane are added to a sodium alginate solution with a mass concentration of 1%, the stirring temperature is 12°C, the stirring time is 4.5h, and when the color of the solution turns black, it proves that polydopamine is synthesized in the sodium alginate solution to obtain a sodium alginate / polydopamine solution.

[0067] Step 3, in situ synthesis of zinc oxide:

[0068] Using sodium alginate as a template, add 0.1 mol / L zinc acetate solution + 0.1 mol / L zinc nitrate and 0.1 mol / L calcium hydroxide solution into the sodium alginate solution in a mass ratio of 110:8:12, stir at 60°C for 2 hours. When the color of the solution turns milky white, it proves that zinc oxide is successfully synthesized to obtain a sodium alginate / zinc oxide solution.

[0069] Step 4, preparing seaweed fiber:

[0070] Sodium alginate / polydopamine solution and sodium alginate / zinc oxide solution were mixed in a mass ratio of 110:120, and the mixed solution was injected into a 1% strontium chloride coagulation bath through a spinneret using a syringe pump to carry out chelating cross-linking of sodium alginate into fibers at a cross-linking temperature of 30°C. The obtained fibers were washed with deionized water and dried to obtain seaweed fibers with photothermally controllable antibacterial functions.

[0071] Comparative Example 1

[0072] Zinc oxide particles are added to a sodium alginate solution, and the sodium alginate solution containing composite zinc oxide is injected into a 1% copper chloride coagulation bath through a spinneret using an injection pump to chelate and crosslink the sodium alginate into fibers at a crosslinking temperature of 10°C. The fibers are then washed with deionized water to obtain an antibacterial seaweed fiber.

[0073] The antibacterial fiber materials obtained in the above Examples 1-3 and the comparative example were subjected to irradiation sterilization treatment and then subjected to relevant performance tests. The specific test contents and material properties are shown in Table 1 below.

[0074] Table 1 Comparison of performance of antibacterial fiber materials of Examples 1-3 and Comparative Examples

[0075]

[0076]

[0077] Figure 1 As can be seen from Figure 2 (a) and (b), the seaweed fiber of the present invention has good photothermal response function and thermal stability, and its maximum temperature can reach about 70°C. Figure 3It can be seen that the photothermally controllable antibacterial seaweed fiber of the present invention has excellent inhibitory effects on Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa, and its antibacterial effect is more significant under the photothermal assisted antibacterial effect of polydopamine. In combination with the above embodiments and Table 1, it can be seen that the photothermally controllable antibacterial seaweed fiber prepared by the present invention not only maintains the biocompatibility, degradability, moisture absorption and water retention of alginate materials and polydopamine, but also gives the material good photothermally controllable antibacterial function, good moisture absorption and air permeability, and lasting antibacterial property. Its wet tensile strength is not less than 2.5KPa, the dry tensile strength is not less than 20KPa, the water absorption rate is not less than 200%, the effect of inhibiting Escherichia coli in the composite antibacterial material is not less than 2mm, the effect of Staphylococcus aureus is not less than 3mm, the effect of inhibiting Pseudomonas aeruginosa is not less than 1mm, and the zinc ion release time can reach 7 days; at the same time, it has photothermally controllable antibacterial function characteristics. The photothermally controllable antibacterial seaweed fiber material prepared by the method of the present invention is a polymer composite material with good processing performance.

[0078] The present invention is not limited to the above-mentioned embodiments. On the basis of the technical solution disclosed in the present invention, technicians in this field can make some substitutions and deformations to some technical features therein according to the disclosed technical content without creative labor, and these substitutions and deformations are all within the protection scope of the present invention.

Claims

1. A method for preparing seaweed fiber with photothermal controllable antibacterial function, characterized in that: The steps include: (a) adding dopamine hydrochloride and tris(hydroxymethylaminomethane) to a sodium alginate solution in a ratio of 10-50% of the mass of dopamine hydrochloride to the mass of sodium alginate and 1-10% of the mass of tris(hydroxymethylaminomethane) to the mass of sodium alginate, stirring and reacting to obtain a sodium alginate / polydopamine solution; (b) adding a zinc salt solution and an alkaline solution to the sodium alginate solution in a mass ratio of (100-120):(8-14):(12-16), heating and stirring to react, and obtaining a sodium alginate / zinc oxide solution; (c) mixing a sodium alginate / polydopamine solution with a sodium alginate / zinc oxide solution in a mass ratio of (100-120):(120-150), injecting the mixed solution into a metal salt aqueous solution coagulation bath through a spinneret hole using a syringe pump, and chelating and cross-linking the sodium alginate into fibers; The obtained fibers are washed with deionized water and dried to obtain seaweed fibers.

2. The method for preparing seaweed fiber with photothermal controllable antibacterial function according to claim 1, characterized in that: The mass concentration of the sodium alginate solution is 0.5-5%.

3. The method for preparing seaweed fiber with photothermal controllable antibacterial function according to claim 1, characterized in that: The stirring temperature of dopamine hydrochloride in the sodium alginate solution is 10-30° C. and the stirring time is 4-8 hours.

4. The method for preparing seaweed fiber with photothermal controllable antibacterial function according to claim 1, characterized in that: The zinc salt is one or more of zinc sulfate, zinc nitrate, zinc chloride and zinc acetate.

5. The method for preparing seaweed fiber with photothermal controllable antibacterial function according to claim 1, characterized in that: The alkaline solution is one or more of a sodium hydroxide solution, a potassium hydroxide solution and a calcium hydroxide solution.

6. The method for preparing seaweed fiber with photothermal controllable antibacterial function according to claim 1, characterized in that: The concentration of the zinc salt solution is 0.1-0.25 mol / L; the concentration of the alkaline solution is 0.1-1 mol / L; the stirring temperature is 40-60°C, and the stirring time is 2-4 hours.

7. The method for preparing seaweed fiber with photothermal controllable antibacterial function according to claim 1, characterized in that: The metal salt in the metal salt aqueous solution coagulation bath is one or more of calcium chloride, strontium chloride, zinc chloride and copper chloride.

8. The method for preparing seaweed fiber with photothermal controllable antibacterial function according to claim 1, characterized in that: The mass concentration of the metal salt aqueous solution in the coagulation bath is 1-5%; the temperature of the sodium alginate chelating cross-linking fiber forming is 10-30°C.

9. A seaweed fiber with photothermal controllable antibacterial function prepared by the method according to any one of claims 1 to 8.

10. The seaweed fiber with photothermal controllable antibacterial function as claimed in claim 9 is used as an antibacterial medical dressing in the clinical treatment of chronic wound care and postoperative wound repair.

Citation Information

Patent Citations

  • Method for preparing calcium alginate / silver nanoparticle fiber

    CN105999363A

  • Preparation method of highly antibacterial alginate dressing

    CN106581734A

  • PVP-modified sodium alginate / polydopamine composite nano-material and preparation and application thereof

    CN110404070A

  • High-strength alginate / nano zinc oxide composite fiber and preparation method thereof

    CN112195647A

Cited By

  • Composite fiber antibacterial bandage and preparation method thereof

    CN119754018A

  • Dopamine / oxidized sodium alginate composite photo-thermal hydrogel fiber and preparation method thereof

    CN119932764A

  • Dopamine / sodium alginate oxide composite photothermal hydrogel fiber and preparation method thereof

    CN119932764B

  • Environment-friendly antibacterial deodorizing fiber fabric and preparation method thereof

    CN120311471A